![]() |
|
|
Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada
Multidrug resistance protein 1 (MRP1) belongs to the ATP-binding cassette superfamily of transport proteins. In addition to drugs, MRP1 mediates the active transport of many conjugated and unconjugated organic anions. MRP1 consists of two membrane-spanning domains (MSD2 and MSD3) each followed by a nucleotide binding domain plus a third NH2-terminal MSD1. MSD2 contains transmembrane (TM) helices 6 through 11, and previously, we identified two charged residues in TM6 as having important but markedly different roles in MRP1 transport activity and substrate specificity by characterizing mutants containing nonconservative substitutions of Lys332 and Asp336. We have now extended these studies and found that the same-charge TM6 mutant K332R, like the nonconservatively substituted Lys332 mutants, exhibits a selective decrease in leukotriene C4 (LTC4) transport, associated with substantial changes in both Km and Vmax and LTC4 binding. The overall organic anion transport activity of the same-charge mutant of Asp336 (D336E) also remained very low, as observed for D336R. In addition, nonconservative substitutions of TM6-associated Lys319 and Lys347 resulted in a selective decrease in GSH transport. Of eight other charged residues in or proximal to TM7 to TM11 that were investigated, nonconservative substitutions of three of them [Lys396 (TM7), Asp436 (TM8), and Arg593 (TM11)] caused a substantial and global reduction in transport activity. However, unlike TM6 Asp336, wild-type transport activity could be reestablished in these MRP1 mutants by conservative substitutions. We conclude that MSD2-charged residues in or proximal to TM6, TM7, TM8, and TM11 play critical but differential roles in MRP1 transport activity and substrate specificity.
Address correspondence to: Dr. Susan P. C. Cole, Cancer Research Laboratories, 3rd Floor, Botterell Hall, Queen's University, Kingston, Ontario K7L 3N6 Canada. E-mail: coles{at}post.queensu.ca
This article has been cited by other articles:
![]() |
Ashutosh, S. Sundar, and N. Goyal Molecular mechanisms of antimony resistance in Leishmania J. Med. Microbiol., February 1, 2007; 56(2): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rothnie, R. Callaghan, R. G. Deeley, and S. P. C. Cole Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1) J. Biol. Chem., May 19, 2006; 281(20): 13906 - 13914. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Zhang, K. Nunoya, M. Vasa, H.-M. Gu, S. P. C. Cole, and R. G. Deeley MUTATIONAL ANALYSIS OF POLAR AMINO ACID RESIDUES WITHIN PREDICTED TRANSMEMBRANE HELICES 10 AND 16 OF MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1): EFFECT ON SUBSTRATE SPECIFICITY Drug Metab. Dispos., April 1, 2006; 34(4): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Conseil, R. G. Deeley, and S. P. C. Cole Functional Importance of Three Basic Residues Clustered at the Cytosolic Interface of Transmembrane Helix 15 in the Multidrug and Organic Anion Transporter MRP1 (ABCC1) J. Biol. Chem., January 6, 2006; 281(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wu, C. J. Oleschuk, Q. Mao, B. O. Keller, R. G. Deeley, and S. P. C. Cole Analysis of Human Multidrug Resistance Protein 1 (ABCC1) by Matrix-Assisted Laser Desorption Ionization/Time of Flight Mass Spectrometry: Toward Identification of Leukotriene C4 Binding Sites Mol. Pharmacol., November 1, 2005; 68(5): 1455 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Situ, A. Haimeur, G. Conseil, K. E. Sparks, D. Zhang, R. G. Deeley, and S. P. C. Cole Mutational Analysis of Ionizable Residues Proximal to the Cytoplasmic Interface of Membrane Spanning Domain 3 of the Multidrug Resistance Protein, MRP1 (ABCC1): GLUTAMATE 1204 IS IMPORTANT FOR BOTH THE EXPRESSION AND CATALYTIC ACTIVITY OF THE TRANSPORTER J. Biol. Chem., September 10, 2004; 279(37): 38871 - 38880. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, A. Haimeur, and M. P. Waalkes Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1): EVIDENCE THAT A TRI-GLUTATHIONE CONJUGATE IS REQUIRED J. Biol. Chem., July 30, 2004; 279(31): 32700 - 32708. [Abstract] [Full Text] [PDF] |
||||